The Dow Chemical Company has announced the widespread availability of nine developmental olefin block copolymers (OBCs), which will be marketed as Infuse OBCs upon commercialization. Customers around the world can now purchase large-volume quantities of these developmental OBCs without the requirement for confidentiality agreements.
"Dow continues to experience strong interest in OBCs, and – in line with the Company's strategic agenda of preferentially investing in its Performance businesses – we are working diligently to bring these first-of-their-kind materials to customers on a high-volume, global scale," said Marco Levi, global business director for plastomers, elastomers and ethylene propylene diene monomer (EPDM), The Dow Chemical Company. "The broad availability of these developmental OBCs will allow us to significantly expand trialing and application development efforts with customers and, ultimately, work with them to increase the market for OBC-based end-use products."
Infuse OBCs feature unique block architecture that allows for new-to-the-world combinations of performance and processing enhancements. This material innovation was created using Insite Technology, which enables olefin elastomers to expand into a wide range of potential market applications for converters and manufacturers of flexible goods and products.